render_searchpagetitle(); ?> render_searchpagemetatags(); ?>
Search - Add URL - Join The Lab
Found 874 results for the keyword important safety. Time 0.004 seconds.
RINVOQ® (upadacitinib) for Rheumatoid ArthritisLearn about RINVOQ® (upadacitinib) for the treatment of moderate to severe Rheumatoid Arthritis (RA) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
Psoriatic Arthritis Treatment | SKYRIZI® (risankizumab-rzaa)See information for healthcare professionals on SKYRIZI for the treatment of active psoriatic arthritis in adults. See Important Safety Information and Prescribing Information.
Important Safety and Performance Information for gammaCoreSee this page for important safety information on gammaCore non-invasive vagus nerve stimulator (nVNS).
RINVOQ® (upadacitinib) for Atopic DermatitisLearn about RINVOQ® (upadacitinib), a JAK inhibitor for the treatment of refractory, moderate to severe Atopic Dermatitis (AD) in patients 12+ years. See full Prescribing Information and Important Safety Information, inc
RINVOQ® (upadacitinib) for Psoriatic ArthritisLearn about RINVOQ® (upadacitinib) for the treatment of active Psoriatic Arthritis (PsA) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
RINVOQ® (upadacitinib) for Ulcerative ColitisLearn about RINVOQ® (upadacitinib) for the treatment of moderate to severe Ulcerative Colitis (UC) in appropriate adult patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING
RINVOQ® (upadacitinib) - Official Healthcare Professional SiteLearn about RINVOQ® (upadacitinib), approved for RA, PsA, AS, nr-axSpA, pJIA, GCA, AD, UC, and CD. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
RINVOQ® (upadacitinib) for Crohn s DiseaseLearn about RINVOQ® for the treatment of moderate to severe Crohn s Disease (CD) in appropriate adult patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
SKYRIZI® (risankizumab-rzaa) – Biologic for Crohn s DiseaseSKYRIZI® is indicated for the treatment of moderate to severe Crohn’s disease (CD) in adults. See Important Safety Information and Prescribing Information.
SKYRIZI® (risankizumab-rzaa) - Biologic for Ulcerative ColitisSKYRIZI® is indicated for the treatment of adults with moderate to severe ulcerative colitis (UC). See Important Safety Information and Prescribing Information.
|
Sponsored Results
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less | ||
|
To process your query we did a search for the keyphrases important safety << Previous - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - Next >> |
|
Didn't find what you were searching for? You can add a new website to the index, remove your site from the search results using the robots.txt protocol or tell us how you would like the results by sending us a message using the email address below:
|
Recent searches:
UC - QV - UU - ZZ - LR
anjali vishwakarma - GV - LM - BL - QS
Copyright (C) 2007 - 2026 Text Ad King and SecretSearchEngineLabs.com. All Rights Reserved.
Terms and Conditions - Privacy Policy - Advertising - About Us - Login